PR

Patel Rameshbhai

Active Director Director DIN 10396699
DIN 10396699 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Patel Rameshbhai

Data last updated:

Patel Rameshbhai is a Director at Thundersky Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Thundersky Pharmaceuticals Private Limited reported revenue of ₹3.35 Cr (FY 2025).

DIN 10396699
Primary Designation Director
Industry Paper
First Appointment 19 Nov 2023
Oldest Company Age 2 yrs
Largest company Thundersky Pharmaceuticals Private Limited · ₹3.35 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Nov 20232023₹3.35 Cr (FY 2025)Active

Board colleagues of Patel Rameshbhai

NameDINCompanyDesignation
Jayshreeben Patel10396700Thundersky Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Thundersky Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Patel Rameshbhai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Patel Rameshbhai

Patel Rameshbhai currently holds 1 directorship: Thundersky Pharmaceuticals Private Limited (Director, since 19 Nov 2023, revenue ₹3.35 Cr (FY 2025)).

Patel Rameshbhai was first appointed on 19 Nov 2023 as Director at Thundersky Pharmaceuticals Private Limited.

The current boards of Patel Rameshbhai's companies include Jayshreeben Patel (Thundersky Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available